Found: 19
Select item for more details and to access through your institution.
Editorial: outcomes following a second switch—evaluating clinical outcomes and patient perspectives in IBD.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1038, doi. 10.1111/apt.16325
- By:
- Publication type:
- Article
Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti‐TNF‐α: results from the ENEIDA registry.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1021, doi. 10.1111/apt.16315
- By:
- Publication type:
- Article
Letter: increased incidence of tissue transglutaminase antibody in Israel—is it always related to coeliac disease? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1053, doi. 10.1111/apt.16343
- By:
- Publication type:
- Article
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B‐related compensated cirrhosis—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1042, doi. 10.1111/apt.16339
- By:
- Publication type:
- Article
Letter: vedolizumab or a second anti‐TNF—no difference in efficacy for primary biologic failures with IBD. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1046, doi. 10.1111/apt.16352
- By:
- Publication type:
- Article
Letter: tenofovir may be superior to entecavir for treatment‐naïve chronic hepatitis B patients—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1050, doi. 10.1111/apt.16340
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 977, doi. 10.1111/apt.16335
- By:
- Publication type:
- Article
Letter: genetic variation in the HLA‐DQA1*05 allele predicts tumour necrosis factor‐α antagonist immunogenicity – does location matter?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1055, doi. 10.1111/apt.16338
- By:
- Publication type:
- Article
Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1030, doi. 10.1111/apt.16324
- By:
- Publication type:
- Article
Letter: tenofovir may be superior to entecavir for treatment‐naïve chronic hepatitis B patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1048, doi. 10.1111/apt.16323
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: risk factors for Barrett's oesophagus in individuals with gastro‐oesophageal reflux symptoms.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 968, doi. 10.1111/apt.16321
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1057, doi. 10.1111/apt.16329
- Publication type:
- Article
Letter: increased incidence of tissue anti‐transglutaminase antibody in Israel—is it always related to coeliac disease?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1051, doi. 10.1111/apt.16320
- By:
- Publication type:
- Article
Randomised clinical trial: a 12‐strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 999, doi. 10.1111/apt.16309
- By:
- Publication type:
- Article
Review article: comprehensive analysis of cirrhotic cardiomyopathy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 985, doi. 10.1111/apt.16305
- By:
- Publication type:
- Article
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B‐related compensated cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1040, doi. 10.1111/apt.16273
- By:
- Publication type:
- Article
Randomised study: effects of the 5‐HT<sub>4</sub> receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1010, doi. 10.1111/apt.16304
- By:
- Publication type:
- Article
Letter: vedolizumab or a second anti‐TNF—no difference in efficacy for primary biologic failures with IBD.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1044, doi. 10.1111/apt.16301
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 965, doi. 10.1111/apt.15846
- Publication type:
- Article